Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02394028
Brief Title: A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease (BERGAMOT)

First Submitted : February 27, 2015
First Submitted that Met QC Criteria : March 16, 2015
First Posted : March 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 5, 2021
Last Update Posted : July 7, 2021